Gut microbiota distinguishes aging hispanics with Alzheimer’s disease: associations with cognitive impairment and severity

Gut microbiota distinguishes aging hispanics with Alzheimer’s disease: associations with cognitive impairment and severity

Abstract Alzheimer’s disease (AD) is a neurodegenerative disorder that begins with memory loss and can lead to death. In Puerto Rico, AD is the fourth leading cause of death, while in the United States, it ranks fifth. Research suggests the gut microbiome contributes to the pathophysiology of AD by...

Full description

Saved in:
Bibliographic Details
Main Authors: Vanessa Sepúlveda-Rivera, Gerianne Olivieri-Henry, Hiram Morales-González, Javier Ruiz-Adames, Carlos Herrero-Rivera, Alexandra Rentas-Echeverria, Valerie Cardona-Berdecia, Cecilia Soler-Llompart, Ana C. Sala-Morales, Guillermo Pérez-Montero, Eric Blanco-Ruiz, Filipa Godoy-Vitorino
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Alzheimer’s disease
Gut microbiota
APOE
Online Access:https://doi.org/10.1038/s41598-025-13262-2
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Alzheimer’s disease (AD) is a neurodegenerative disorder that begins with memory loss and can lead to death. In Puerto Rico, AD is the fourth leading cause of death, while in the United States, it ranks fifth. Research suggests the gut microbiome contributes to the pathophysiology of AD by promoting inflammation and amyloid buildup in the brain. This study examined the composition and diversity of the gut microbiota in Puerto Ricans with AD compared to controls and its relationship with cognitive impairment severity and APOE status. We recruited 100 participants (50 AD, 50 controls), who underwent clinical and cognitive assessments (MoCA/CDR). While overall microbial diversity and richness showed no significant differences, specific bacterial taxa exhibited subtle differential abundance. Faecalibacterium and Bacteroides were moderately significant and increased on controls compared to AD. Moreover, individuals carrying the APOE E4 allele exhibited lower abundances of butyrate-producing bacteria and an enrichment of potentially pro-inflammatory genera, including Eggerthella and Lachnoclostridium. These findings suggest that gut microbiota dysbiosis may contribute to cognitive decline and AD progression, highlighting the potential for microbiome-targeted therapeutic interventions in AD prevention and treatment.
ISSN:2045-2322

Similar Items